Zobrazeno 1 - 10
of 181
pro vyhledávání: '"Gar-Yang Chau"'
Autor:
I-Cheng Lee, Hao-Jan Lei, Lei-Chi Wang, Yi-Chen Yeh, Gar-Yang Chau, Cheng-Yuan Hsia, Shu-Cheng Chou, Jiing-Chyuan Luo, Ming-Chih Hou, Yi-Hsiang Huang
Publikováno v:
Liver Cancer, Pp 1-12 (2024)
Introduction: Novel biomarkers reflecting liver fibrosis and the immune microenvironment may correlate with the risk of hepatocellular carcinoma (HCC) recurrence. This study aimed to evaluate the prognostic value of serum biomarkers in predicting HCC
Externí odkaz:
https://doaj.org/article/bf1c593010c14be5ba581b8737efb264
Autor:
Chun-Yang Lee, Gar-Yang Chau, Cheng-Yi Wei, Yee Chao, Yi-Hsiang Huang, Teh-Ia Huo, Ming-Chih Hou, Yu-Hui Su, Jaw-Ching Wu, Chien-Wei Su
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract We investigated the outcomes of patients with ruptured hepatocellular carcinoma (HCC) and identified the optimal treatment modality for such patients. We retrospectively enrolled 91 patients with treatment-naive HCC and tumor rupture at diag
Externí odkaz:
https://doaj.org/article/e831e7417d424e70aebcc8468c272c0e
Autor:
I-Cheng Lee, Jo-Yu Huang, Ting-Chun Chen, Chia-Heng Yen, Nai-Chi Chiu, Hsuen-En Hwang, Jia-Guan Huang, Chien-An Liu, Gar-Yang Chau, Rheun-Chuan Lee, Yi-Ping Hung, Yee Chao, Shinn-Ying Ho, Yi-Hsiang Huang
Publikováno v:
Liver Cancer, Pp 1-11 (2021)
Background and Aims: Current prediction models for early recurrence of hepatocellular carcinoma (HCC) after surgical resection remain unsatisfactory. The aim of this study was to develop evolutionary learning-derived prediction models with interpreta
Externí odkaz:
https://doaj.org/article/0150fb40bc8c4f028ff59c41089db392
Autor:
Chi-Jung Wu, Gar-Yang Chau, I-Cheng Lee, Teh-Ia Huo, Chien-Wei Su, Ming-Chih Hou, Yi-Hsiang Huang
Publikováno v:
Journal of the Formosan Medical Association, Vol 120, Iss 8, Pp 1563-1571 (2021)
Background/Purpose: Hepatocellular carcinoma (HCC) is a highly recurrent tumor. Antiviral therapy with nucleos(t)ide analogues (NUCs) may reduce the risk of recurrence in hepatitis B virus (HBV)-related HCC. The risk factors associated with recurrenc
Externí odkaz:
https://doaj.org/article/d76af01758394f2ab9ef288e4430713e
Autor:
Shih-Hao Young, Gar-Yang Chau, I-Cheng Lee, Yi-Chen Yeh, Yee Chao, Teh-Ia Huo, Chien-Wei Su, Han-Chieh Lin, Ming-Chih Hou, Mei-Hsuan Lee, Yi-Hsiang Huang
Publikováno v:
Journal of the Formosan Medical Association, Vol 119, Iss 1, Pp 218-229 (2020)
Background/Purpose: The risk of recurrence after resection of hepatocellular carcinoma (HCC) is high. Apart from nucleos(t)ide analogues therapy, population-based studies suggest statin, nonsteroidal anti-inflammatory drugs (NSAIDs) and aspirin have
Externí odkaz:
https://doaj.org/article/470cefde517843e890f9f39fb21f4bbe
Autor:
Chen-Ta Chi, Gar-Yang Chau, Rheun-Chuan Lee, Yen-Ying Chen, Hao-Jan Lei, Ming-Chih Hou, Yee Chao, Yi-Hsiang Huang
Publikováno v:
Journal of the Formosan Medical Association, Vol 119, Iss 1, Pp 125-133 (2020)
Background/Purpose: Combined hepatocellular-cholangiocarcinoma (cHCC-CCA) is a rare primary liver cancer. Preoperative diagnosis of cHCC-CCA is difficult, and outcome of cHCC-CCA is obscured. Our study aimed to investigate the clinicopathological and
Externí odkaz:
https://doaj.org/article/733f9535eea644ab8aa6c2d139efd424
Publikováno v:
Frontiers in Medicine, Vol 8 (2022)
BackgroundThis study aimed to investigate the influential factors of postoperative pain trajectories and morphine consumption after hepatic cancer surgery with a particular interest in multimodal analgesia.MethodsPatients receiving hepatic cancer sur
Externí odkaz:
https://doaj.org/article/289fc8dd469a4ab3a6692b9c4f98b132
Autor:
Hon-Fan Lai, Ivy Yenwen Chau, Hao-Jan Lei, Shu-Cheng Chou, Cheng-Yuan Hsia, Yi-Chu Kao, Gar-Yang Chau
Publikováno v:
PLoS ONE, Vol 17, Iss 1, p e0262113 (2022)
PurposeTo evaluate the incidence and risk factors of postoperative fever (POF) after liver resection. In patients with POF, predictors of febrile infectious complications were determined.MethodsA total of 797 consecutive patients undergoing liver res
Externí odkaz:
https://doaj.org/article/6a75e886caa647e7acbf7f56df96631d
Autor:
Kwong-Ming Kee, Chien-Hung Chen, Jui-Ting Hu, Yi-Hsiang Huang, Tsang-En Wang, Gar-Yang Chau, Kuo-Hsin Chen, Yao-Li Chen, Chih-Che Lin, Chien-Fu Hung, Shiu-Feng Huang, Tsang-Wu Liu, Hsiu-Ying Ku, Bing-Shen Huang, Yi-Pin Wang, Hui-Ping Tseng, Chun-Ju Chiang, Sheng-Nan Lu
Publikováno v:
Viruses, Vol 15, Iss 1, p 126 (2022)
Hepatocellular carcinoma (HCC) is a major cause of cancer death in Taiwan, and in the past 30–40 years, Taiwan has been committed to its prevention and treatment. We aimed to investigate the secular trends of characteristics and the survival of HCC
Externí odkaz:
https://doaj.org/article/680dc7a220944016bfb1d3e8762b29cd
Autor:
Chih‐Li Chen, Yu‐Shuen Tsai, Yen‐Hua Huang, Yuh‐Jin Liang, Ya‐Yun Sun, Chien‐Wei Su, Gar‐Yang Chau, Yi‐Chen Yeh, Yung‐Sheng Chang, Jui‐Ting Hu, Jaw‐Ching Wu
Publikováno v:
Hepatology Communications, Vol 2, Iss 11, Pp 1392-1407 (2018)
Lymphoid enhancer factor 1 (LEF1) activity is associated with progression of several types of cancers. The role of LEF1 in progression of hepatocellular carcinoma (HCC) remains poorly known. We investigated LEF1 expression in HCC and its interactions
Externí odkaz:
https://doaj.org/article/0005d62db0a740039803f2ea121212ef